Figure 3From: Cetuximab and radiation for primary and recurrent squamous cell carcinoma of the head and neck (SCCHN) in the elderly and multi-morbid patient: a single-centre experienceOverall PFS, n = 69 pts; Mean 21.3 months; 95% CI: 16.3 - 26.3 months.Back to article page